Chaturvedi S, Malik MY, Rashid M, Singh S, Tiwari V, Gupta P, Shukla S, Singh S, Wahajuddin M. Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: Possible role of nitric oxide isoforms and inflammatory cytokines. Neurotoxicology. July 2020, 79: 1–10. Bibcode:2020NeuTx..79....1C. PMID 32151614. doi:10.1016/j.neuro.2020.03.002.
Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. January 2010, 50 (Suppl 1): S16–23. PMID 20067388. doi:10.1086/647939.
Rawat A, Singh P, Jyoti A, Kaushik S, Srivastava VK. Averting transmission: A pivotal target to manage amoebiasis. Chemical Biology & Drug Design. August 2020, 96 (2): 731–744. PMID 32356312. S2CID 218475533. doi:10.1111/cbdd.13699.
Nori D, Cain JM, Hilaris BS, Jones WB, Lewis JL. Metronidazole as a radiosensitizer and high-dose radiation in advanced vulvovaginal malignancies, a pilot study. Gynecologic Oncology. August 1983, 16 (1): 117–28. PMID 6884824. doi:10.1016/0090-8258(83)90017-3.
Sarna JR, Furtado S, Brownell AK. Neurologic complications of metronidazole. The Canadian Journal of Neurological Sciences. November 2013, 40 (6): 768–776. PMID 24257215. doi:10.1017/s0317167100015870.
Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, Lindeløv B, Jørgensen K. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiotherapy and Oncology. February 1998, 46 (2): 135–46. PMID 9510041. doi:10.1016/s0167-8140(97)00220-x.
Karamanakos PN, Pappas P, Boumba VA, Thomas C, Malamas M, Vougiouklakis T, Marselos M. Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines. International Journal of Toxicology. 2007, 26 (5): 423–432. PMID 17963129. S2CID 41230661. doi:10.1080/10915810701583010.
Chaturvedi S, Malik MY, Rashid M, Singh S, Tiwari V, Gupta P, Shukla S, Singh S, Wahajuddin M. Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: Possible role of nitric oxide isoforms and inflammatory cytokines. Neurotoxicology. July 2020, 79: 1–10. Bibcode:2020NeuTx..79....1C. PMID 32151614. doi:10.1016/j.neuro.2020.03.002.
Cina SJ, Russell RA, Conradi SE. Sudden death due to metronidazole/ethanol interaction. The American Journal of Forensic Medicine and Pathology. December 1996, 17 (4): 343–346. PMID 8947362. doi:10.1097/00000433-199612000-00013.
Kudo T, Endo Y, Taguchi R, Yatsu M, Ito K. Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. May 2015, 45 (5): 413–419. PMID 25470432. S2CID 26910995. doi:10.3109/00498254.2014.990948.
Tirkkonen T, Heikkilä P, Huupponen R, Laine K. Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. Journal of Internal Medicine. October 2010, 268 (4): 359–366. PMID 20698928. S2CID 45449460. doi:10.1111/j.1365-2796.2010.02257.x.
Alauzet C, Aujoulat F, Lozniewski A, Marchandin H. A sequence database analysis of 5-nitroimidazole reductase and related proteins to expand knowledge on enzymes responsible for metronidazole inactivation. Anaerobe. February 2019, 55: 29–34. PMID 30315962. doi:10.1016/j.anaerobe.2018.10.005.
World Health Organization. The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. 2023. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. January 2010, 50 (Suppl 1): S16–23. PMID 20067388. doi:10.1086/647939.
Huang Y, Shen C, Shen Y, Cui H. Assessing the Efficacy of Clotrimazole and Metronidazole Combined Treatment in Vaginitis: A Meta-Analysis. Altern Ther Health Med. January 2024, 30 (1): 186–191. PMID 37773671.
Rawat A, Singh P, Jyoti A, Kaushik S, Srivastava VK. Averting transmission: A pivotal target to manage amoebiasis. Chemical Biology & Drug Design. August 2020, 96 (2): 731–744. PMID 32356312. S2CID 218475533. doi:10.1111/cbdd.13699.
Nori D, Cain JM, Hilaris BS, Jones WB, Lewis JL. Metronidazole as a radiosensitizer and high-dose radiation in advanced vulvovaginal malignancies, a pilot study. Gynecologic Oncology. August 1983, 16 (1): 117–28. PMID 6884824. doi:10.1016/0090-8258(83)90017-3.
Sarna JR, Furtado S, Brownell AK. Neurologic complications of metronidazole. The Canadian Journal of Neurological Sciences. November 2013, 40 (6): 768–776. PMID 24257215. doi:10.1017/s0317167100015870.
Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, Lindeløv B, Jørgensen K. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiotherapy and Oncology. February 1998, 46 (2): 135–46. PMID 9510041. doi:10.1016/s0167-8140(97)00220-x.
Karamanakos PN, Pappas P, Boumba VA, Thomas C, Malamas M, Vougiouklakis T, Marselos M. Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines. International Journal of Toxicology. 2007, 26 (5): 423–432. PMID 17963129. S2CID 41230661. doi:10.1080/10915810701583010.
Karamanakos PN. The possibility of serotonin syndrome brought about by the use of metronidazole. Minerva Anestesiologica. November 2008, 74 (11): 679. PMID 18971895.
Chaturvedi S, Malik MY, Rashid M, Singh S, Tiwari V, Gupta P, Shukla S, Singh S, Wahajuddin M. Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: Possible role of nitric oxide isoforms and inflammatory cytokines. Neurotoxicology. July 2020, 79: 1–10. Bibcode:2020NeuTx..79....1C. PMID 32151614. doi:10.1016/j.neuro.2020.03.002.
Cina SJ, Russell RA, Conradi SE. Sudden death due to metronidazole/ethanol interaction. The American Journal of Forensic Medicine and Pathology. December 1996, 17 (4): 343–346. PMID 8947362. doi:10.1097/00000433-199612000-00013.
Kudo T, Endo Y, Taguchi R, Yatsu M, Ito K. Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. May 2015, 45 (5): 413–419. PMID 25470432. S2CID 26910995. doi:10.3109/00498254.2014.990948.
Tirkkonen T, Heikkilä P, Huupponen R, Laine K. Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. Journal of Internal Medicine. October 2010, 268 (4): 359–366. PMID 20698928. S2CID 45449460. doi:10.1111/j.1365-2796.2010.02257.x.
Alauzet C, Aujoulat F, Lozniewski A, Marchandin H. A sequence database analysis of 5-nitroimidazole reductase and related proteins to expand knowledge on enzymes responsible for metronidazole inactivation. Anaerobe. February 2019, 55: 29–34. PMID 30315962. doi:10.1016/j.anaerobe.2018.10.005.
Rawat A, Singh P, Jyoti A, Kaushik S, Srivastava VK. Averting transmission: A pivotal target to manage amoebiasis. Chemical Biology & Drug Design. August 2020, 96 (2): 731–744. PMID 32356312. S2CID 218475533. doi:10.1111/cbdd.13699.
Karamanakos PN, Pappas P, Boumba VA, Thomas C, Malamas M, Vougiouklakis T, Marselos M. Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines. International Journal of Toxicology. 2007, 26 (5): 423–432. PMID 17963129. S2CID 41230661. doi:10.1080/10915810701583010.
Kudo T, Endo Y, Taguchi R, Yatsu M, Ito K. Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. May 2015, 45 (5): 413–419. PMID 25470432. S2CID 26910995. doi:10.3109/00498254.2014.990948.
Tirkkonen T, Heikkilä P, Huupponen R, Laine K. Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. Journal of Internal Medicine. October 2010, 268 (4): 359–366. PMID 20698928. S2CID 45449460. doi:10.1111/j.1365-2796.2010.02257.x.
Kraft MY, Kochergin PM, Tsyganova AM, Shlikhunova VS. Synthesis of metronidazole from ethylenediamine. Pharmaceutical Chemistry Journal. 1989, 23 (10): 861–863. S2CID 38187002. doi:10.1007/BF00764821.